I agree with you Maza was out there working a deal as an attendee. A lot of the Biotechs at the conference are there with CEO's Executive level management. He is a former Goldman investment banker and they are one of best at getting deals done for companies. The ILNS patent portfolio with OX1 and TAU just to name a few have value IMO. Big Pharma with multi-billions in cash picks ILNS up easily dropping multi million dollar deal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.